Observational studyRevista de neurologia2025
[Gross Motor Function after Rehabilitation with the Atlas 2030 Pediatric Exoskeleton in Children With Cerebral Palsy].
Observational study in Revista de neurologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07066956 (Impacto Del Exoesqueleto Infantil Atlas 2030 en la Funcionalidad de la Marcha y en la Calidad de Vida de Niños Con Parálisis Cerebral Infantil o Patologías Afines), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Impacto Del Exoesqueleto Infantil Atlas 2030 en la Funcionalidad de la Marcha y en la Calidad de Vida de Niños Con Parálisis Cerebral Infantil o Patologías Afines
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
INTRODUCTION AND
objectivesTo evaluate the impact of intensive gait training on gross motor function using the pediatric exoskeleton ATLAS 2030, as well as to determine the post-intervention maintenance of effects in children with cerebral palsy (CP). SUBJECTS AND
methodsA non-randomized controlled prospective study. Thirteen children with CP participated. A program of four weekly sessions lasting 65 minutes each was implemented over six weeks. Gross motor function was assessed using the 88 items Gross Motor Function Measure (GMFM-88); physical exercise endurance was measured with the Six-Minute Walk Test (6MWT) using the device; the number of steps walked in each session and mode of use was recorded to evaluate adaptation to the activity. Three evaluations were conducted: before treatment, at the end of treatment (6 weeks), and a follow-up evaluation at 12 weeks.
resultsThe total GMFM-88 score showed significant changes at the end of the intervention (p < 0.001), which persisted at follow-up (p < 0.001). The number of steps in automatic and active modes increased significantly after the intervention (p < 0.001) and were maintained at follow-up (p = 0.001). Lastly, the 6MWT improved significantly after the intervention, with a reduction observed at follow-up (p < 0.001).
conclusionsSix weeks of intensive training with ATLAS 2030 positively impacts the gross motor function of children with CP, with benefits increasing six weeks after treatment completion. Physical endurance and adaptation to the activity improve with continued use. These results support the potential of ATLAS 2030 as an intensive therapeutic strategy for this population. CLINICAL
trial registrationNo: NCT07066956. https://clinicaltrials.gov/search?cond=NCT07066956.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.